Firefly Neuroscience, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report, dated August 5, 2026, covers events occurring at Firefly Neuroscience, Inc.'s 2026 Annual Meeting of Stockholders. The company is a Delaware corporation with its principal executive offices in Kenmore, NY, and its common stock trades on the Nasdaq Capital Market under the symbol AIFF.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data. The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Corporate Actions
- Charter Amendment: Stockholders approved a reduction in the total number of authorized shares from 5,001,000,000 to 101,000,000. The new authorization consists of 100,000,000 shares of Common Stock and 1,000,000 shares of Preferred Stock. This amendment became effective on August 5, 2026.
- Equity Plan Amendment: Stockholders approved Amendment No. 2 to the 2024 Long-Term Incentive Plan, increasing the maximum number of shares available for grant by 2,000,000 shares and updating the plan's evergreen provision.
- Director Election: Arun Menawat was elected as a Class III director to serve until the 2029 annual meeting.
- Accounting Firm Ratification: CBIZ Canada, LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Executive Compensation: The advisory proposal regarding named executive officer compensation was approved.
Outlook, Risks, and Voting Results
The filing details the voting results for six proposals, all of which were approved. As of the record date (June 8, 2026), there were 15,604,571 shares outstanding, with 9,703,536 shares present or represented by proxy, constituting a quorum. The filing does not contain specific management commentary on future outlook, risks, contingencies, or unusual items beyond the standard incorporation by reference to the Proxy Statement.
Key Facts for Investor Verification
- Verify the impact of the significant reduction in authorized shares (from ~5 billion to 101 million) on future capital raising capabilities.
- Review the full text of the 2024 Long-Term Incentive Plan Amendment (Exhibit 10.1) to understand the updated evergreen provision mechanics.
- Confirm the details of the new independent auditor, CBIZ Canada, LLP, and their scope of engagement.
- Check the Definitive Proxy Statement (filed July 9, 2026) for detailed rationale behind the charter amendment and equity plan changes.